Does a 43-year-old patient with hypotestosteronemia (low total testosterone) but normal free testosterone levels, and normal Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH) levels meet the criteria for testosterone replacement therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

A 43-year-old patient with low total testosterone but normal free testosterone levels on two separate blood tests, along with normal FSH and LH levels, does not meet the criteria for testosterone replacement therapy. This recommendation is based on the guidelines from the American College of Physicians, which suggest that testosterone treatment should only be considered in men with age-related low testosterone who have sexual dysfunction and want to improve sexual function 1. The patient's normal free testosterone levels, which are the biologically active form of the hormone, indicate adequate hormonal function despite the low total testosterone.

The discrepancy between total and free testosterone may be due to variations in sex hormone-binding globulin (SHBG) levels, which can be affected by factors like liver disease, thyroid disorders, obesity, or certain medications. According to the American College of Physicians guideline, there is no well-defined threshold of testosterone levels below which symptoms of androgen deficiency and adverse health outcomes occur 1.

Key points to consider in this patient's case include:

  • The presence of normal free testosterone levels, which is the biologically active form of the hormone
  • The absence of symptoms of hypogonadism, such as fatigue, decreased libido, erectile dysfunction, or depression
  • The normal FSH and LH levels, which indicate that the pituitary-gonadal axis is functioning properly
  • The potential causes of the laboratory pattern, such as variations in SHBG levels, which should be evaluated before considering any hormone therapy.

Given the low-certainty evidence and conditional recommendations for testosterone treatment, monitoring rather than treatment would be the appropriate approach for this patient, as suggested by the American College of Physicians guideline 1.

From the Research

Testosterone Replacement Therapy Criteria

  • The patient's total testosterone levels are low, but free testosterone levels are normal, which may not necessarily indicate a need for testosterone replacement therapy 2, 3.
  • The patient's FSH and LH levels are normal, which suggests that the hypothalamic-pituitary-gonadal axis is functioning properly 4, 5.
  • The patient's age (43 years) is within the range where hypogonadism can occur, but it is not a definitive indicator for testosterone replacement therapy 2, 6.

Diagnosis and Treatment Considerations

  • The diagnosis of hypogonadism typically requires a combination of low testosterone levels and symptoms such as decreased libido, erectile dysfunction, fatigue, or osteoporosis 2, 3.
  • Testosterone replacement therapy is generally recommended for patients with symptomatic hypogonadism and low testosterone levels (< 300 ng/dL) 2, 3.
  • Clomiphene citrate is an alternative treatment option for hypogonadism, which can help increase testosterone levels while preserving testicular function 4, 5.

Specific Considerations for This Patient

  • The patient's normal free testosterone levels and normal FSH and LH levels may suggest that testosterone replacement therapy is not necessary 2, 3.
  • However, the patient's low total testosterone levels and potential symptoms (not specified) should be taken into consideration when determining the best course of treatment 2, 6.
  • Further evaluation and monitoring of the patient's symptoms and hormone levels may be necessary to determine the most appropriate treatment plan 3, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Testosterone replacement therapy.

Andrology, 2020

Research

CLOMIPHENE CITRATE IN THE TREATMENT OF IDIOPATHIC OR FUNCTIONAL HYPOGONADOTROPIC HYPOGONADISM IN MEN: A CASE SERIES AND REVIEW OF THE LITERATURE.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2017

Research

Testosterone replacement therapy: clinical considerations.

Expert opinion on pharmacotherapy, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.